A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is
Speaker abstracts 2001
be updated easily at each visit, without a need to collect the data again. Results The CLUE forms have been used to characterise 102 consecutive patients with RA in routine clinical care. Medications in current use included prednisone (median dose 4 mg per day) by 94% of patients, methotrexate (median dose 15 mg per week) by 86%, hydroxycholoroquine by 28%, leflunomide by 10%, cyclosporine by 8%, etanercept by 8%, infliximab by 8%, auranofin by 3%, gold injections by 3%, azathioprine by 2%,doi:10.1136/annrheumdis-2001.1114 fatcat:x7djizxmqrectkknfbwy47fsyi